FIB-4 is a calculation used to help assess the likelihood of advanced liver fibrosis in the right clinical setting. It is not a diagnosis of cirrhosis, a measure of all liver health or a reason to buy repeated scans without a clinical plan.
Evidence checked 1 November 2026. Prepared by The Wellness Team.
What goes into a FIB-4 score?
FIB-4 uses age, the liver enzymes AST and ALT, and the platelet count. It combines existing information rather than directly measuring scar tissue. Ask whether the necessary results were collected in an appropriate clinical setting and whether previous values are available.
Because age is built into the calculation, an identical set of blood results can produce different scores at different ages. A number copied into a general online calculator therefore needs interpretation, not a universal red or green label.
Who is FIB-4 intended to help?
It helps clinicians risk-stratify people in whom metabolic liver disease or fibrosis is a relevant concern. The EASL-EASD-EASO guideline supports case-finding in people with cardiometabolic risk factors, abnormal liver enzymes or imaging evidence of steatosis, especially type 2 diabetes or obesity with additional metabolic risk.
This is different from recommending the same test and scan sequence to every healthy person. The question is whether the result changes a sensible care pathway for you.
Does a high score prove liver scarring?
No. A raised FIB-4 usually signals the need for further assessment rather than proving advanced fibrosis. Low-risk and higher-risk thresholds depend on the setting and age. AASLD highlights reduced reliability in younger adults and the need for different interpretation in older adults.
A clinician may use another non-invasive assessment, such as elastography or a specialist blood test, to clarify risk. The sequence should be explained before testing. Do not interpret a calculator result as a percentage of your liver that is damaged.
Can normal liver enzymes rule out important disease?
Normal-looking liver blood tests do not settle every question about liver fibrosis. Liver enzymes, fat on imaging and scar burden describe different aspects of liver health. A scan that mentions fatty change is not itself a complete fibrosis assessment.
Equally, one abnormal enzyme does not establish a chronic liver condition. Alcohol, medicines, recent illness and other causes may need review. The right response is a clinical history and a proportionate investigation plan, not an automatic diagnosis of metabolic liver disease.
What should I bring to the consultation?
Bring previous liver tests, platelet counts, imaging reports, a current medicine and supplement list, and an honest account of alcohol intake. Include recent illness and relevant family history.
For an executive with several reports from different countries, aligning dates and units can be the most useful first task. If you are visiting London, agree how follow-up will work after you leave. A premium appointment should reduce fragmentation rather than generate a second disconnected set of results.
What is worth paying for beyond the score?
Pay for interpretation, a plan and accountability for the next step, not the appearance of precision. Ask why another test is recommended, what a low or high result would change, when specialist review is appropriate and who will explain it.
Ask The Wellness to review your screening priorities A written quote should separate the consultation, any additional investigation and follow-up, so you can make an informed decision without assuming that a larger package is necessarily better.
What can I do while waiting for review?
Avoid extreme diets or unverified liver-detox products. Discuss sustainable activity, nutrition, alcohol and management of existing metabolic conditions with your clinician. Do not change prescribed treatment because of a FIB-4 number alone.
Jaundice, vomiting blood, confusion or severe acute illness require urgent medical assessment rather than a routine executive check. This article explains risk assessment; it does not provide a treatment plan or establish suitability for any medicine.
Sources and evidence limits
- EASL-EASD-EASO guideline on metabolic dysfunction-associated steatotic liver disease
- AASLD explanation of non-invasive liver fibrosis assessment
This guide explains evidence and questions for a consultation. It does not diagnose your condition or confirm that a test or procedure is appropriate for you.
What should I do next?
Discuss an individual assessment with The Wellness. Bring your previous results, medicines and the question you want answered. Ask for a written plan and quote before deciding to proceed.